Clinical Trials in Seattle

Showing 1261-1280 of 8,049 trials

Multilevel Interventions to Increase Adherence to Lung Cancer Screening

NCT05747443

Screening for lung cancer has the potential for a profound public health benefit. Repeat annual screening is necessary for early detection of lung cancer. The investigators will test two interventions which include patient education and reminders to improve adherence to lung cancer screening.

Lung CancerLung Cancer Screening

Kaiser Permanente1,837 participantsStarted Dec 2022

Seattle, Washington, United States

RECRUITING< 1 mile

Stroke Thrombectomy and Aneurysm Registry

NCT04994756

This international multi-center registry is used to collect existing information and outcomes for patients undergoing an operation for treatment of injuries to the brain including the blockage of blood flow to an area of the brain, an abnormal ballooning of an artery, abnormal tangling of blood vessels, abnormal formation of blood vessels, tearing of vein, and bleeding in the brain. This information is used to help predict outcomes that undergo an operation for treatment of the above-listed brain injuries. Additionally, the information is used to compare techniques and devices' effects on technical and clinical outcomes.

StrokeThromboses, IntracranialAneurysm, Brain

Medical University of South Carolina40,000 participantsStarted Sep 2019

Birmingham, Alabama, United States • Loma Linda, California, United States • Santa Barbara, California, United States +60 more locations

Multilevel Interventions to Increase Adherence to Lung Cancer Screening

Stroke Thrombectomy and Aneurysm Registry

Find Trials by Condition in Seattle

Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

A Study of Axicabtagene Ciloleucel in Participants With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV

Prevention of Colorectal Cancer Through Multiomics Blood Testing

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

SpineTRACK Registry - Spinal Outcomes Registry

Routine vs On-demand ECMO for Lung Transplantation

Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders